Found: 41
Select item for more details and to access through your institution.
Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The expression and clinical significance of programmed cell death receptor 1 and its ligand in tumor tissues of patients with extranodal nasal NK/T cell lymphoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-02515-5
- By:
- Publication type:
- Article
Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in China.
- Published in:
- Frontiers in Pharmacology, 2023, v. 13, p. 1, doi. 10.3389/fphar.2023.979111
- By:
- Publication type:
- Article
Th9 cells promote antitumor immune responses in vivo.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 11, p. 4160, doi. 10.1172/JCI65459
- By:
- Publication type:
- Article
Symptom clusters and quality of life in ambulatory patients with multiple myeloma.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 6, p. 4961, doi. 10.1007/s00520-022-06896-9
- By:
- Publication type:
- Article
Modest survival benefits of autologous stem cell transplantation in multiple myeloma with renal impairment: a critical appraisal of the pre-antibody era.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01481-2
- By:
- Publication type:
- Article
Maintenance therapy for cytogenetically high-risk multiple myeloma: landscape in the era of novel drugs.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01445-6
- By:
- Publication type:
- Article
Daratumumab-based immunotherapy vs. lenalidomide, bortezomib and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: a systemic review.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1286029
- By:
- Publication type:
- Article
Efficacy and safety of histone deacetylase inhibitors in peripheral T-cell lymphoma: a systematic review and meta-analysis on prospective clinical trials.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1127112
- By:
- Publication type:
- Article
Decreased RNA‐binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 2, p. 594, doi. 10.1111/bjh.19468
- By:
- Publication type:
- Article
SLC2A5 overexpression in childhood philadelphia chromosome‐positive acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 2, p. 242, doi. 10.1111/bjh.15580
- By:
- Publication type:
- Article
USP18 is crucial for IFN-gamma-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-132
- By:
- Publication type:
- Article
Minimal residual disease in multiple myeloma: current status.
- Published in:
- Biomarker Research, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40364-021-00328-2
- By:
- Publication type:
- Article
Bone Marrow Stromal Cells Derived MCP-1 Reverses the Inhibitory Effects of Multiple Myeloma Cells on Osteoclastogenesis by Upregulating the RANK Expression.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082453
- By:
- Publication type:
- Article
Low-dose ruxolitinib shows effective in treating myelofibrosis.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 1, p. 135, doi. 10.1007/s00277-020-04311-z
- By:
- Publication type:
- Article
Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone.
- Published in:
- Journal of Molecular Medicine, 2012, v. 90, n. 6, p. 695, doi. 10.1007/s00109-011-0849-9
- By:
- Publication type:
- Article
Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 835, doi. 10.1007/s00262-014-1557-4
- By:
- Publication type:
- Article
CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 4, p. 561, doi. 10.1007/s00262-011-1123-2
- By:
- Publication type:
- Article
Progress in Chimeric Antigen Receptor-Modified Natural Killer Cells for Multiple Myeloma.
- Published in:
- Acta Academiae Medicinae Sinica, 2023, v. 45, n. 2, p. 290, doi. 10.3881/j.issn.1000-503X.14785
- By:
- Publication type:
- Article
A predictive risk‐scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South‐Western China.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 17, p. 1, doi. 10.1002/cam4.70193
- By:
- Publication type:
- Article
Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 14, p. 1, doi. 10.1002/cam4.7435
- By:
- Publication type:
- Article
A stratified therapeutic model incorporated with studies on regulatory B cells for elderly patients with newly diagnosed multiple myeloma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 3054, doi. 10.1002/cam4.5228
- By:
- Publication type:
- Article
AC024896.1/miR-363-3p Axis Regulates the Malignant Progression of Acute Myeloid Leukemia by Cuproptosis-Related Gene MYO1B.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2024, v. 14, p. 17, doi. 10.2147/BLCTT.S454115
- By:
- Publication type:
- Article
p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression.
- Published in:
- Nature Communications, 2014, v. 5, n. 6, p. 4229, doi. 10.1038/ncomms5229
- By:
- Publication type:
- Article
Discrepancies between clinical staging and pathological findings of operable cervical carcinoma with stage IB–IIB: A retrospective analysis of 818 patients.
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2009, v. 49, n. 5, p. 542, doi. 10.1111/j.1479-828X.2009.01065.x
- By:
- Publication type:
- Article
Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91433-7
- By:
- Publication type:
- Article
p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 1, p. 34, doi. 10.1002/ijc.28958
- By:
- Publication type:
- Article
Anti-β<sub>2</sub>M monoclonal antibodies kill myeloma cells via cell- and complement-mediated cytotoxicity.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 5, p. 1132, doi. 10.1002/ijc.28745
- By:
- Publication type:
- Article
Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 8, p. 1, doi. 10.1038/s41419-024-06982-2
- By:
- Publication type:
- Article
Single‐cell sequencing reveals the correlation of aggrephagy signaling and multiple myeloma immune microenvironment composition.
- Published in:
- Journal of Gene Medicine, 2024, v. 26, n. 7, p. 1, doi. 10.1002/jgm.3712
- By:
- Publication type:
- Article
Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 2, p. 172, doi. 10.1002/hon.2956
- By:
- Publication type:
- Article
Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34<sup>+</sup> cells.
- Published in:
- Stem Cell Research & Therapy, 2018, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13287-018-0902-5
- By:
- Publication type:
- Article
Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0356-0
- By:
- Publication type:
- Article
Targeting cell surface β.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 1, p. 111, doi. 10.1111/j.1365-2141.2011.08714.x
- By:
- Publication type:
- Article
Pathogenesis and treatment of multiple myeloma.
- Published in:
- MedComm, 2022, v. 3, n. 2, p. 1, doi. 10.1002/mco2.146
- By:
- Publication type:
- Article
Intravascular large B-cell lymphoma as a covert trigger for hemophagocytic lymphohistiocytosis complicated with capillary leak syndrome: a case report and literature review.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1403376
- By:
- Publication type:
- Article
Estrogen‐Responsive Gene MAST4 Regulates Myeloma Bone Disease.
- Published in:
- Journal of Bone & Mineral Research, 2022, v. 37, n. 4, p. 711, doi. 10.1002/jbmr.4507
- By:
- Publication type:
- Article
Human Osteoclasts are Inducible Immunosuppressive Cells in Response to T cell-Derived IFN-γ and CD40 Ligand In Vitro.
- Published in:
- Journal of Bone & Mineral Research, 2014, v. 29, n. 12, p. 2666, doi. 10.1002/jbmr.2294
- By:
- Publication type:
- Article
Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Multiple Myeloma Based on Bone Marrow Homing.
- Published in:
- Advanced Materials, 2022, v. 34, n. 46, p. 1, doi. 10.1002/adma.202107883
- By:
- Publication type:
- Article
Compassion satisfaction and compassion fatigue in haematology cancer nurses: A cross‐sectional survey.
- Published in:
- Nursing Open, 2022, v. 9, n. 4, p. 2159, doi. 10.1002/nop2.1226
- By:
- Publication type:
- Article
PIM3 Promotes the Proliferation and Migration of Acute Myeloid Leukemia Cells.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 6897, doi. 10.2147/OTT.S245578
- By:
- Publication type:
- Article